Form 10Q Iradimed Co For: 1 May
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iradimed Co (IRMD)
Assess today's live Iradimed Co (IRMD) share price, performance and insights using our live NASDAQ: IRMD stock exchange data.
Analyse the historical data and Iradimed Co share price performance charts on this page. Our technical summary section provides analysis on Iradimed Co share price buy/sell indicators using real-time data (or discuss the Iradimed Co (IRMD) stock price today with other investors in the Iradimed Co NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IRMD share price (ISIN: US46266A1097) to enhance your trading decisions with our free investment tools and resources.
What Is the Iradimed Co Share Price Today?
The Iradimed Co share price today is 87.15.
What Is the Stock Symbol for Iradimed Co
The stock symbol (or 'ticker') for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Iradimed Co share price performance charts on this page. Our technical summary section provides analysis on Iradimed Co share price buy/sell indicators using real-time data (or discuss the Iradimed Co (IRMD) stock price today with other investors in the Iradimed Co NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IRMD share price (ISIN: US46266A1097) to enhance your trading decisions with our free investment tools and resources.
What Is the Iradimed Co Share Price Today?
The Iradimed Co share price today is 87.15.
What Is the Stock Symbol for Iradimed Co
The stock symbol (or 'ticker') for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.95
87.78
52 wk Range
50.31
107.90
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.9587.78
52 wk Range
50.31107.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
118.67
Upside
+36.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Iradimed CEO Susi sells $697k in shares
- Investing.com
- Iradimed CEO Susi sells $717k in IRMD stock
- Investing.com
- Form 10Q Iradimed Co For: 1 May
- Investing.com
- Iradimed CEO Roger Susi sells $694k in common stock
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 118.67
(+36.16% Upside)
Iradimed Co Earnings Call Summary for Q1/2026
- Q1 2026 EPS of $0.49 beat forecast of $0.46; revenue hit $22M vs. expected $20.8M, though stock fell 2.7% in pre-market trading
- Company maintained 78% gross margin and achieved 16th consecutive quarter of record revenues in MRI-compatible medical devices
- FDA-cleared MRidium 3870 launch expected to drive future growth; CEO Roger Susi cited technological advances as pivotal for adoption
- FY2026 EPS guidance set at $2.10, rising to $2.35 for FY2027; company earned 'GREAT' financial health score with strong liquidity
- Key risks include supply chain disruptions, market saturation from competition, and macroeconomic pressures affecting hospital budgets
Last Updated: 01/05/2026, 16:44
Read Full TranscriptEarnings
Latest Release
01/05/2026
EPS / Forecast
0.49 / 0.46
Revenue / Forecast
22M / 20.8M
Compare IRMD to Peers and Sector
Metrics to compare | IRMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.6x | 18.2x | −0.5x | |
PEG Ratio | - | 0.05 | 0.00 | |
Price/Book | 11.8x | 7.3x | 2.6x | |
Price / LTM Sales | 13.3x | 2.4x | 3.2x | |
Upside (Analyst Target) | 37.7% | 56.0% | 48.1% | |
Fair Value Upside | Unlock | 3.3% | 6.6% | Unlock |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Iradimed Co (NASDAQ: IRMD) Share Price Today?
The Iradimed Co stock price today is 87.15 USD.
What Stock Exchange Does Iradimed Co (IRMD) Trade On?
Iradimed Co is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Iradimed Co?
The stock symbol (also called a 'ticker') for Iradimed Co is "IRMD."
Does Iradimed Co Pay Dividends? What’s The Current IRMD Dividend Yield?
Yes, IRMD Pays Dividends to its Shareholders. The current Iradimed Co dividend yield is 0.96%.
What Is the Current Iradimed Co Market Capitalisation?
As of today, Iradimed Co (NASDAQ: IRMD) market cap is 1.11B USD.
What Is Iradimed Co's (IRMD) Earnings Per Share (TTM)?
The Iradimed Co EPS is currently 1.75 (Trailing Twelve Months).
When Is the Next Iradimed Co Earnings Date?
Iradimed Co's next earnings report will be released on 30/07/2026.
Is IRMD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Iradimed Co moving averages and other technical indicators, the daily buy/sell signal for IRMD stock is Strong Sell.
How Many Times Has Iradimed Co Stock Split?
Iradimed Co has split 0 times. (See the IRMD stock split history page for full effective split date and price information.)
How Many Employees Does Iradimed Co Have?
Iradimed Co has 166 employees, based on their latest Companies House report.
What is the current trading status of Iradimed Co (NASDAQ: IRMD)?
As of 03/05/2026, Iradimed Co (IRMD) is trading at a share price of 87.15 USD, with a previous close of 83.44 USD. The stock has fluctuated within a day range of 76.95 USD to 87.78 USD, while its 52-week range spans from 50.31 USD to 107.90 USD.
What Is Iradimed Co (IRMD) Price Target According to Analysts?
The average 12-month price target for Iradimed Co is 118.67 USD, with a high estimate of 120 USD and a low estimate of 116 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.16% Upside potential.
What Is the IRMD Premarket Price?
IRMD's last pre-market stock price is 81.19 USD. The pre-market share volume is 300.00, and the stock has decreased by -2.25, or -2.70%.
What Is the IRMD After Hours Price?
IRMD's last after hours stock price is 87.75 USD, the stock has decreased by 0.60, or 0.69%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.